These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22082957)

  • 1. Regional lymphatic immunity in melanoma.
    Grotz TE; Mansfield AS; Jakub JW; Markovic SN
    Melanoma Res; 2012 Feb; 22(1):9-18. PubMed ID: 22082957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor lymphangiogenesis and melanoma metastasis.
    Rinderknecht M; Detmar M
    J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy and melanoma biology.
    Essner R
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2320s-2325s. PubMed ID: 16609052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
    Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
    J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of the immunohistological state of the lymph nodes regional to a tumor].
    Serov AA
    Biull Eksp Biol Med; 1980 Feb; 89(2):196-8. PubMed ID: 6966167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathobiology of the sentinel node.
    Cochran AJ; Ohsie SJ; Binder SW
    Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic analysis of sentinel lymph nodes in melanoma patients: current and future trends.
    Roberts AA; Cochran AJ
    J Surg Oncol; 2004 Mar; 85(3):152-61. PubMed ID: 14991887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Ulceration and lymph node metastasis of skin melanomas on the germinal centers of regional lymph nodes].
    Weidner F; Schroll S; Schönberger A; Hornstein OP
    Pathologe; 1982 Jul; 3(4):184-7. PubMed ID: 6981109
    [No Abstract]   [Full Text] [Related]  

  • 12. Regional lymph node dissections in malignant melanoma.
    Lawton GP; Ariyan S
    Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.
    Schietroma C; Cianfarani F; Lacal PM; Odorisio T; Orecchia A; Kanitakis J; D'Atri S; Failla CM; Zambruno G
    Cancer; 2003 Aug; 98(4):789-97. PubMed ID: 12910524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies.
    Cochran AJ; Pihl E; Wen DR; Hoon DS; Korn EL
    J Natl Cancer Inst; 1987 Mar; 78(3):399-405. PubMed ID: 3469453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of the lymph nodes in patients with malignant melanoma.
    Cochran AJ; Robert ME; Wen DR
    Pathology (Phila); 1994; 2(2):385-400. PubMed ID: 9420909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis.
    Mansfield AS; Holtan SG; Grotz TE; Allred JB; Jakub JW; Erickson LA; Markovic SN
    Mod Pathol; 2011 Apr; 24(4):487-94. PubMed ID: 21151098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
    Ruddell A; Kelly-Spratt KS; Furuya M; Parghi SS; Kemp CJ
    Oncogene; 2008 May; 27(22):3145-55. PubMed ID: 18059331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.